The global Fragment-based Drug Discovery market size was valued at USD 342.4 million in 2023 and is forecast to a readjusted size of USD 522.5 million by 2030 with a CAGR of 6.2% during review period.
The introduction of new techniques into the existing fragment-based drug discovery practices have created significant reductions in time and cost, driving the demand for such practices.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report includes an overview of the development of the Fragment-based Drug Discovery industry chain, the market status of Academic and Research Institutions (Fragment Screening, Fragment Optimization), Biopharmaceutical Companies (Fragment Screening, Fragment Optimization), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Fragment-based Drug Discovery.
Regionally, the report analyzes the Fragment-based Drug Discovery markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Fragment-based Drug Discovery market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Fragment-based Drug Discovery market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Fragment-based Drug Discovery industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Fragment Screening, Fragment Optimization).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Fragment-based Drug Discovery market.
Regional Analysis: The report involves examining the Fragment-based Drug Discovery market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Fragment-based Drug Discovery market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Fragment-based Drug Discovery:
Company Analysis: Report covers individual Fragment-based Drug Discovery players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Fragment-based Drug Discovery This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Academic and Research Institutions, Biopharmaceutical Companies).
Technology Analysis: Report covers specific technologies relevant to Fragment-based Drug Discovery. It assesses the current state, advancements, and potential future developments in Fragment-based Drug Discovery areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Fragment-based Drug Discovery market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Fragment-based Drug Discovery market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Fragment Screening
Fragment Optimization
Market segment by Application
Academic and Research Institutions
Biopharmaceutical Companies
Contract Research Organizations (CROs)
Market segment by players, this report covers
Astex Pharmaceuticals
Alveus Pharmaceuticals
Beactica
Charles River Laboratories
Crown Bioscience
Emerald BioStructures
Evotec
Kinetic Discovery
Proteros Fragments
Sprint Bioscience
Structure Based Design
Sygnature Discovery
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Fragment-based Drug Discovery product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Fragment-based Drug Discovery, with revenue, gross margin and global market share of Fragment-based Drug Discovery from 2019 to 2024.
Chapter 3, the Fragment-based Drug Discovery competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Fragment-based Drug Discovery market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Fragment-based Drug Discovery.
Chapter 13, to describe Fragment-based Drug Discovery research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope of Fragment-based Drug Discovery
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Fragment-based Drug Discovery by Type
1.3.1 Overview: Global Fragment-based Drug Discovery Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Fragment-based Drug Discovery Consumption Value Market Share by Type in 2023
1.3.3 Fragment Screening
1.3.4 Fragment Optimization
1.4 Global Fragment-based Drug Discovery Market by Application
1.4.1 Overview: Global Fragment-based Drug Discovery Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Academic and Research Institutions
1.4.3 Biopharmaceutical Companies
1.4.4 Contract Research Organizations (CROs)
1.5 Global Fragment-based Drug Discovery Market Size & Forecast
1.6 Global Fragment-based Drug Discovery Market Size and Forecast by Region
1.6.1 Global Fragment-based Drug Discovery Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Fragment-based Drug Discovery Market Size by Region, (2019-2030)
1.6.3 North America Fragment-based Drug Discovery Market Size and Prospect (2019-2030)
1.6.4 Europe Fragment-based Drug Discovery Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Fragment-based Drug Discovery Market Size and Prospect (2019-2030)
1.6.6 South America Fragment-based Drug Discovery Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Fragment-based Drug Discovery Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 Astex Pharmaceuticals
2.1.1 Astex Pharmaceuticals Details
2.1.2 Astex Pharmaceuticals Major Business
2.1.3 Astex Pharmaceuticals Fragment-based Drug Discovery Product and Solutions
2.1.4 Astex Pharmaceuticals Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Astex Pharmaceuticals Recent Developments and Future Plans
2.2 Alveus Pharmaceuticals
2.2.1 Alveus Pharmaceuticals Details
2.2.2 Alveus Pharmaceuticals Major Business
2.2.3 Alveus Pharmaceuticals Fragment-based Drug Discovery Product and Solutions
2.2.4 Alveus Pharmaceuticals Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Alveus Pharmaceuticals Recent Developments and Future Plans
2.3 Beactica
2.3.1 Beactica Details
2.3.2 Beactica Major Business
2.3.3 Beactica Fragment-based Drug Discovery Product and Solutions
2.3.4 Beactica Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Beactica Recent Developments and Future Plans
2.4 Charles River Laboratories
2.4.1 Charles River Laboratories Details
2.4.2 Charles River Laboratories Major Business
2.4.3 Charles River Laboratories Fragment-based Drug Discovery Product and Solutions
2.4.4 Charles River Laboratories Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Charles River Laboratories Recent Developments and Future Plans
2.5 Crown Bioscience
2.5.1 Crown Bioscience Details
2.5.2 Crown Bioscience Major Business
2.5.3 Crown Bioscience Fragment-based Drug Discovery Product and Solutions
2.5.4 Crown Bioscience Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Crown Bioscience Recent Developments and Future Plans
2.6 Emerald BioStructures
2.6.1 Emerald BioStructures Details
2.6.2 Emerald BioStructures Major Business
2.6.3 Emerald BioStructures Fragment-based Drug Discovery Product and Solutions
2.6.4 Emerald BioStructures Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Emerald BioStructures Recent Developments and Future Plans
2.7 Evotec
2.7.1 Evotec Details
2.7.2 Evotec Major Business
2.7.3 Evotec Fragment-based Drug Discovery Product and Solutions
2.7.4 Evotec Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Evotec Recent Developments and Future Plans
2.8 Kinetic Discovery
2.8.1 Kinetic Discovery Details
2.8.2 Kinetic Discovery Major Business
2.8.3 Kinetic Discovery Fragment-based Drug Discovery Product and Solutions
2.8.4 Kinetic Discovery Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Kinetic Discovery Recent Developments and Future Plans
2.9 Proteros Fragments
2.9.1 Proteros Fragments Details
2.9.2 Proteros Fragments Major Business
2.9.3 Proteros Fragments Fragment-based Drug Discovery Product and Solutions
2.9.4 Proteros Fragments Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Proteros Fragments Recent Developments and Future Plans
2.10 Sprint Bioscience
2.10.1 Sprint Bioscience Details
2.10.2 Sprint Bioscience Major Business
2.10.3 Sprint Bioscience Fragment-based Drug Discovery Product and Solutions
2.10.4 Sprint Bioscience Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Sprint Bioscience Recent Developments and Future Plans
2.11 Structure Based Design
2.11.1 Structure Based Design Details
2.11.2 Structure Based Design Major Business
2.11.3 Structure Based Design Fragment-based Drug Discovery Product and Solutions
2.11.4 Structure Based Design Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Structure Based Design Recent Developments and Future Plans
2.12 Sygnature Discovery
2.12.1 Sygnature Discovery Details
2.12.2 Sygnature Discovery Major Business
2.12.3 Sygnature Discovery Fragment-based Drug Discovery Product and Solutions
2.12.4 Sygnature Discovery Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Sygnature Discovery Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Fragment-based Drug Discovery Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Fragment-based Drug Discovery by Company Revenue
3.2.2 Top 3 Fragment-based Drug Discovery Players Market Share in 2023
3.2.3 Top 6 Fragment-based Drug Discovery Players Market Share in 2023
3.3 Fragment-based Drug Discovery Market: Overall Company Footprint Analysis
3.3.1 Fragment-based Drug Discovery Market: Region Footprint
3.3.2 Fragment-based Drug Discovery Market: Company Product Type Footprint
3.3.3 Fragment-based Drug Discovery Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Fragment-based Drug Discovery Consumption Value and Market Share by Type (2019-2024)
4.2 Global Fragment-based Drug Discovery Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
5.1 Global Fragment-based Drug Discovery Consumption Value Market Share by Application (2019-2024)
5.2 Global Fragment-based Drug Discovery Market Forecast by Application (2025-2030)
6 North America
6.1 North America Fragment-based Drug Discovery Consumption Value by Type (2019-2030)
6.2 North America Fragment-based Drug Discovery Consumption Value by Application (2019-2030)
6.3 North America Fragment-based Drug Discovery Market Size by Country
6.3.1 North America Fragment-based Drug Discovery Consumption Value by Country (2019-2030)
6.3.2 United States Fragment-based Drug Discovery Market Size and Forecast (2019-2030)
6.3.3 Canada Fragment-based Drug Discovery Market Size and Forecast (2019-2030)
6.3.4 Mexico Fragment-based Drug Discovery Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe Fragment-based Drug Discovery Consumption Value by Type (2019-2030)
7.2 Europe Fragment-based Drug Discovery Consumption Value by Application (2019-2030)
7.3 Europe Fragment-based Drug Discovery Market Size by Country
7.3.1 Europe Fragment-based Drug Discovery Consumption Value by Country (2019-2030)
7.3.2 Germany Fragment-based Drug Discovery Market Size and Forecast (2019-2030)
7.3.3 France Fragment-based Drug Discovery Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Fragment-based Drug Discovery Market Size and Forecast (2019-2030)
7.3.5 Russia Fragment-based Drug Discovery Market Size and Forecast (2019-2030)
7.3.6 Italy Fragment-based Drug Discovery Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Fragment-based Drug Discovery Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Fragment-based Drug Discovery Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Fragment-based Drug Discovery Market Size by Region
8.3.1 Asia-Pacific Fragment-based Drug Discovery Consumption Value by Region (2019-2030)
8.3.2 China Fragment-based Drug Discovery Market Size and Forecast (2019-2030)
8.3.3 Japan Fragment-based Drug Discovery Market Size and Forecast (2019-2030)
8.3.4 South Korea Fragment-based Drug Discovery Market Size and Forecast (2019-2030)
8.3.5 India Fragment-based Drug Discovery Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Fragment-based Drug Discovery Market Size and Forecast (2019-2030)
8.3.7 Australia Fragment-based Drug Discovery Market Size and Forecast (2019-2030)
9 South America
9.1 South America Fragment-based Drug Discovery Consumption Value by Type (2019-2030)
9.2 South America Fragment-based Drug Discovery Consumption Value by Application (2019-2030)
9.3 South America Fragment-based Drug Discovery Market Size by Country
9.3.1 South America Fragment-based Drug Discovery Consumption Value by Country (2019-2030)
9.3.2 Brazil Fragment-based Drug Discovery Market Size and Forecast (2019-2030)
9.3.3 Argentina Fragment-based Drug Discovery Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Fragment-based Drug Discovery Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Fragment-based Drug Discovery Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Fragment-based Drug Discovery Market Size by Country
10.3.1 Middle East & Africa Fragment-based Drug Discovery Consumption Value by Country (2019-2030)
10.3.2 Turkey Fragment-based Drug Discovery Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Fragment-based Drug Discovery Market Size and Forecast (2019-2030)
10.3.4 UAE Fragment-based Drug Discovery Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 Fragment-based Drug Discovery Market Drivers
11.2 Fragment-based Drug Discovery Market Restraints
11.3 Fragment-based Drug Discovery Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Fragment-based Drug Discovery Industry Chain
12.2 Fragment-based Drug Discovery Upstream Analysis
12.3 Fragment-based Drug Discovery Midstream Analysis
12.4 Fragment-based Drug Discovery Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Astex Pharmaceuticals
Alveus Pharmaceuticals
Beactica
Charles River Laboratories
Crown Bioscience
Emerald BioStructures
Evotec
Kinetic Discovery
Proteros Fragments
Sprint Bioscience
Structure Based Design
Sygnature Discovery
听
听
*If Applicable.
